Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ford

Showing results (951-960 of 1,097) with videos related to

Pageof 110
Sort By:
Therapeutic Advances in Medical Oncology|January 5, 2026
Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancerDongli Liu, Michelle Wong-Brown, Farhana Amy Sarker, et al.
The American Journal of Cardiology|April 19, 2024
Kidney and Cardiovascular Effectiveness of Empagliflozin Compared With Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 DiabetesDaniel Edmonston, Hillary Mulder, Elizabeth Lydon, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C proteaseA K Patick, S L Binford, M A Brothers, et al.
Archives of Internal Medicine|May 13, 2009
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analysesJackson T Wright, Jeffrey L Probstfield, William C Cushman, et al.
Family & Community Health|June 10, 2010
Community-based participatory research in Indian country: improving health through water quality research and awarenessCrescentia Cummins, John Doyle, Larry Kindness, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acidsP S Dragovich, S E Webber, T J Prins, et al.
Molecular Cancer Research : MCR|September 28, 2016
Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading TumorsLuke B Hesson, Benedict Ng, Peter Zarzour, et al.
Clinical Nephrology|December 1, 2016
Association between chronic kidney disease and cancer mortality: A report from the ALLHATDhruti P Chen, Barry R Davis, Lara M Simpson, et al.
Contemporary Clinical Trials|May 31, 2024
Selecting trial centers using a standardized, automated site assessment survey instrument (SASI)Karen Lane, Shannon Hillery, Ryan Majkowski, et al.
Journal of Medicinal Chemistry|May 5, 2000
Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluationS H Reich, T Johnson, M B Wallace, et al.
Pageof 110

Showing results (951-960 of 1,097) with videos related to

Sort By:
Pageof 110
Therapeutic Advances in Medical Oncology|January 5, 2026
Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancerDongli Liu, Michelle Wong-Brown, Farhana Amy Sarker, et al.
The American Journal of Cardiology|April 19, 2024
Kidney and Cardiovascular Effectiveness of Empagliflozin Compared With Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 DiabetesDaniel Edmonston, Hillary Mulder, Elizabeth Lydon, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C proteaseA K Patick, S L Binford, M A Brothers, et al.
Archives of Internal Medicine|May 13, 2009
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analysesJackson T Wright, Jeffrey L Probstfield, William C Cushman, et al.
Family & Community Health|June 10, 2010
Community-based participatory research in Indian country: improving health through water quality research and awarenessCrescentia Cummins, John Doyle, Larry Kindness, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acidsP S Dragovich, S E Webber, T J Prins, et al.
Molecular Cancer Research : MCR|September 28, 2016
Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading TumorsLuke B Hesson, Benedict Ng, Peter Zarzour, et al.
Clinical Nephrology|December 1, 2016
Association between chronic kidney disease and cancer mortality: A report from the ALLHATDhruti P Chen, Barry R Davis, Lara M Simpson, et al.
Contemporary Clinical Trials|May 31, 2024
Selecting trial centers using a standardized, automated site assessment survey instrument (SASI)Karen Lane, Shannon Hillery, Ryan Majkowski, et al.
Journal of Medicinal Chemistry|May 5, 2000
Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluationS H Reich, T Johnson, M B Wallace, et al.
Pageof 110